Skip to content

LSD: all studies

Page 139 of 282: studies 1,381 to 1,390 of 2,816, newest first. Back to the LSD overview

Research

Stereospecific Actions of DOET (2,5-Dimethoxy-4-Ethylamphetamine) in Man

Archives of General Psychiatry July 1, 1974 Solomon H. Snyder 25 citations

Several different molecular conformations of psychedelic drugs have been proposed to explain the very similar effects of drugs with markedly divergent chemical structures, such as mescaline andd-lysergic acid diethylamide (LSD). In some of these models, the α-carbon of methoxyamphetamine psychedelics approximates the asymmetric carbon No. 5 of LSD predicting that the (-) "R" isomer of the...

FURTHER STUDIES ON THE MODE OF ACTION OF PSYCHOTOMIMETIC DRUGS: ANTAGONISM OF THE EXCITATORY ACTIONS OF 5‐HYDROXYTRYPTAMINE BY METHYLATED DERIVATIVES OF TRYPTAMINE

British Journal of Pharmacology March 1, 1974 Philip Bradley, Ian Briggs 54 citations

The actions of 5‐methoxytryptamine (5‐MeOT), N,N ‐dimethyltryptamine (DMT), 5‐hydroxy‐ N,N ‐dimethyltryptamine (bufotenine, 5‐HODMT) and 5‐methoxy‐ N,N ‐dimethyltryptamine (5‐MeODMT), and their interactions with 5‐hydroxytryptamine (5‐HT), acetylcholine, (–)‐noradrenaline, and glutamate were studied by microiontophoresis on single neurones in the brain stem of rats anaesthetized with urethane...

DOET(2,5-Dimethoxy-4-Ethylamphetamine), a New Psychotropic Drug

Archives of General Psychiatry 1971 Solomon H. Snyder 30 citations

DOET (2,5-dimethoxy-4-ethylamphetamine) is a new psychotropic agent which chemically resembles mescaline and amphetamine. It is essentially the ethyl homologue of DOM (2,5-dimethoxy-4-methylamphetamine), a psychotomimetic drug widely used by hippie populations and designated "STP." DOET was administered to normal male subjects in doses ranging from 0.75 to 4 mg and contrasted with effects of a...

Effects of infused tryptamine in man

Psychopharmacologia September 1, 1970 W. R. Martin, J. W. Sloan

Tryptamine, infused intravenously in man, facilitates the patellar reflex, dilates pupils and elevates blood pressure. It also causes changes in vision and hearing, as well as nausea, vomiting, dizziness, sweating and heaviness of body. These changes are similar to those produced by LSD-like hallucinogens and are consistent with the hypothesis that LSD-like hallucinogens interact with...

DOI: 10.1007/bf00412669 (opens in new tab) Full text (opens in new tab) LSD Tryptamine Subjective effects Drug-induced psychosis

Steric and Electronic Relationships among Some Hallucinogenic Compounds

Proceedings of the National Academy of Sciences September 1, 1970 Sungzong Kang, Jack Peter Green 64 citations

Stereochemical considerations and total valence electron calculations suggest congruities among the ostensibly dissimilar hallucinogenic compounds, D-lysergic acid diethylamide (LSD), indolcalkylamines, and methoxylated amphetamines. In LSD the aromatic benzene ring A and the N-6 nitrogen are essential for hallucinogenic activity; these sites may react with the receptor. The conformations of...

DOM (STP), a New Hallucinogenic Drug, and DOET: Effects in Normal Subjects

American Journal of Psychiatry September 1, 1968 Solomon H. Snyder, Louis A. Faillace, Herbert Weingartner 77 citations

DOM, a hallucinogen related to mescaline and amphetamine and designated "STP" by hippies, along with DOET, the ethyl homologue of DOM, were given in small doses to normal subjects in a double-blind study. Both drugs increased self-awareness and produced mild euphoria but no hallucinogenic or psychotomimetic effects. The two drugs "freed up" subjects' word associations without impairing memory...

The Psychedelic Experience - A New Concept in Psychotherapy

Journal of Psychedelic Drugs April 1, 1968 Janet Sherwood, Myron J. Stolaroff, Willis W. Harman 24 citations

Abstract The authors, by the simultaneous administration of massive doses of lysergic acid diethylamide (LSD) and mescaline, tried to produce a unique experience for the patient which is to be so profound and impressive that it changes the patient's own evaluation of his past life experiences and consequently may lead him to establish new values and a more realistic frame of reference than had...

2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug

Science November 3, 1967 Solomon H. Snyder, Louis A. Faillace, Leo E. Hollister 146 citations

We have assessed the effects in normal control volunteers of 2,5-dimethoxy-4-methyl-amphetamine, the chemical present in the hallucinogenic drug STP, in two independent trials. In low doses, this compound produces a mild euphoria. Doses greater than 3 milligrams may cause pronounced hallucinogenic effects lasting about 8 hours and similar to those produced by hallucinogenic doses of lysergic...

Dynamics of Psychedelic Drug Abuse

Archives of General Psychiatry May 1, 1967 Malcolm B. Bowers 22 citations

THE PUBLIC has become aware of the increasing use of the major psychedelic substances (lysergic acid diethylamide [LSD], peyote, psilocybin, morning glory seeds) by certain individuals outside the contexts of supervised therapy and research.1,2Several excellent clinical studies have firmly documented the hazards of this Practice.4,5At a time when the scientific community has been gathering...

XXXVIII. Comparison with Action of Methysergide and Psilocybin on Test Subjects

Journal of Asthma Research 1965 Harold A. Abramson, Anabela P. Rolo 21 citations

This paper is a continuation of our experiments with LSD-25 and similar compounds that have been carried out for the last thirteen years.1 It employs the same technique described previously2 to compare these drugs on non-psychotic test subjects under suitable conditions. The conditions of the experiment are most important because under certain circumstances the experimental milieu produces so...